We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$336M
Cap. Flow
+$603M
Cap. Flow %
41.48%
Top 10 Hldgs %
67.23%
Holding
768
New
375
Increased
70
Reduced
59
Closed
238

Sector Composition

Rank Sector Weight
1 Healthcare 11.15%
2 Financials 9.75%
3 Technology 2.87%
4 Industrials 2.67%
5 Consumer Discretionary 1.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRVL
751
CALL
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
-20,000
Closed -$2K
PRVL
752
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
-5,523
Closed -$127K
PRVL
753
PUT
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
-22,000
Closed -$39K
FIT
754
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
-487,900
Closed -$13K
FIT
755
DELISTED
Fitbit, Inc. Class A common stock
FIT
-490,000
Closed -$3.33M
FIT
756
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
-1,214,100
Closed -$332K
PE
757
CALL
DELISTED
PARSLEY ENERGY INC
PE
-50,000
Closed -$16K
TIF
758
CALL
DELISTED
Tiffany & Co.
TIF
-59,900
Closed -$1K
TIF
759
PUT
DELISTED
Tiffany & Co.
TIF
-599,300
Closed -$42K
BMY.RT
760
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
-350,000
Closed -$242K
NGHC
761
DELISTED
National General Holdings Corp
NGHC
-604,700
Closed -$20.7M
NGHC
762
PUT
DELISTED
National General Holdings Corp
NGHC
-603,000
Closed -$45K
BEAT
763
CALL
DELISTED
BioTelemetry, Inc.
BEAT
-20,000
Closed -$7K
REV
764
PUT
DELISTED
Revlon, Inc.
REV
-224,500
Closed -$158K
MCF
765
DELISTED
Contango Oil & Gas Co.
MCF
-180,000
Closed -$412K
UFS
766
CALL
DELISTED
DOMTAR CORPORATION (New)
UFS
-159,200
Closed -$337K
UFS
767
DELISTED
DOMTAR CORPORATION (New)
UFS
-55,000
Closed -$1.74M
UFS
768
PUT
DELISTED
DOMTAR CORPORATION (New)
UFS
-75,000
Closed -$4K

Similar funds

Cowen and Company's Q1 2021 Portfolio in Review

As of Q1 2021, Cowen and Company held 768 positions worth $1.45B, up 30% from $1.12B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Cowen and Company deployed $603M of net new capital in Q1 2021, opening 375 new positions and adding to 70 existing holdings. Its largest new stake was iTeos Therapeutics: 588,238 shares worth $20.1M.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 4.9% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Freeport-McMoran, an estimated $5.42M trimmed.

  • Cowen and Company's largest Q1 2021 buy was iTeos Therapeutics: 588,238 shares worth $20.1M.
  • Cowen and Company added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2021, an estimated $151M increase.
  • Cowen and Company's biggest Q1 2021 reduction was Freeport-McMoran, cutting an estimated $5.42M.
  • Cowen and Company fully exited VanEck Semiconductor ETF in Q1 2021, selling an estimated $30.8M.
  • Cowen and Company's ten largest holdings make up 67% of its $1.45B portfolio in Q1 2021.
  • Cowen and Company opened 375 new positions and closed 238 in Q1 2021.
  • Cowen and Company's portfolio value rose 30% quarter-over-quarter to $1.45B.

Based on Cowen and Company's 13F filing for Q1 2021, filed 4 May 2021.